Synonyms:MEGESTROL ACETATE, 595-33-5, Megace, Megestryl acetate, Megace ES, Niagestin, Megeron, Megestat, Ovaban, Ovarid, BDH 1298, Maygace, Pallace, Magestin, SC 10363, NSC-71423, Volidan, SC10363, 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, Megesterol acetate, 17alpha-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone, 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone, 17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, Megestrol-17-acetate, SC-10363, 17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione, BDH-1298, 6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate, TJ2M0FR8ES, Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-, Megestrol 17.alpha.-acetate, MLS000028633, MLS001074091, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate, DTXSID9040683, BDH1298, 6-Methyl-3,20-dioxopregna-4,6-dien-17-yl acetate, SMR000058691, Megestil, 6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione, Ovaban (Veterinary), 51154-23-5, DTXCID7020683, 6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone, MegestrolAcetate, 6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate, Megestrol acetate [USAN], (8xi,9xi,10xi,13xi,14xi)-6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate, CCRIS 372, Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, acetate, EINECS 209-864-5, UNII-TJ2M0FR8ES, Megestin, Megestrol acetole [Progestins], Megestrol acetate [USAN:USP], Megestrol acetole, Megestrol-Acetate, 17-alpha-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17-alpha-acetoxyprogesterone, 6-Methyl-6-dehydro-17-alpha-acetoxyprogesterone, NCGC00016516-01, (8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate, CAS-595-33-5, Megace (TN), 17alpha-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 6-Methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione, 6-Methyl-17-alpha-hydroxy-delta(sup 6)-progesterone acetate, 6-Methyl-6-dehydro-17.alpha.-acetylprogesterone, 6-Methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone, 6-Methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione acetate, 17.alpha.-Acetoxy-6-dehydro-6-methylprogesterone, 6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone, 6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone, Megestrol acetate (USP), Opera_ID_1511, Prestwick0_000956, Prestwick1_000956, Prestwick2_000956, Prestwick3_000956, 6-Methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione acetate, SCHEMBL745, BSPBio_000952, MLS000759501, MLS001424055, par-100,2, SPBio_003101, MEGESTROL ACETATE [MI], BPBio1_001048, CHEBI:6723, CHEMBL1201139, MEGESTROL ACETATE [VANDF], MEGESTROL ACETATE [MART.], BCPP000168, HMS1570P14, HMS2051I20, HMS2090N04, HMS2097P14, HMS2235D16, HMS3714P14, MEGESTROL ACETATE [USP-RS], MEGESTROL ACETATE [WHO-DD], MEGESTROL ACETATE [WHO-IP], Nia, NSC71423, Tox21_110469, Tox21_302360, LMST02030118, MFCD00056470, s1304, AKOS015894927, MEGESTROL ACETATE [GREEN BOOK], Tox21_110469_1, BCP9000904, CCG-100899, CS-2065, DB00351, MEGESTROL ACETATE [ORANGE BOOK], NC00149, MEGESTROL ACETATE [EP MONOGRAPH], 17-Acetoxy-6-methylpregna-4,20-dione, MEGESTROL ACETATE [USP MONOGRAPH], NCGC00024196-03, NCGC00024196-05, NCGC00255456-01, AC-24570, AS-13384, HY-13676, 17.alpha.-Acetoxy-6-methyl-4,20-dione, AB00490013, 17-Hydroxy-6-methylpregna-4,20-dione acetate, 17.alpha.-Acetoxy-6-methylpregna-4,20-dione, C08151, D00952, D91560, AB00383046-13, AB00383046-14, AB00383046-15, AB00383046_16, EN300-7480847, Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-, A832354, SR-01000000258, Megestrol-17-acetate 100 microg/mL in Acetonitrile, Pregna-4,20-dione, 17-hydroxy-6-methyl-, acetate, Q-201346, Q6808975, SR-01000000258-4, BRD-K19507340-001-03-1, MEDROXYPROGESTERONE ACETATE IMPURITY G [WHO-IP], Megestrol acetate, VETRANAL(TM), analytical standard, 17alpha-Acetoxy-6-methyl-4,6-pregnadiene-3,20-dione, Megestrol acetate, analytical standard, for drug analysis, MEDROXYPROGESTERONE ACETATE IMPURITY G [EP IMPURITY], WLN: L E5 B666 OV KU MUTJ A1 E1 FV1 FOV1 L1, 6-Methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone acetate, Megestrol acetate, European Pharmacopoeia (EP) Reference Standard, 6-METHYL-3,20-DIOXOPREGNA-4,6-DIEN-17-YL ACETATE [WHO-IP], Megestrol acetate, United States Pharmacopeia (USP) Reference Standard, Megesgtrol Acetate, Pharmaceutical Secondary Standard; Certified Reference Material, Megestrol acetate for peak identification, European Pharmacopoeia (EP) Reference Standard, Megestrol acetate for system suitability, European Pharmacopoeia (EP) Reference Standard, (1R,3aS,3bR,9aR,9bS,11aS)-1-acetyl-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate
Pubchem:PUBCHEM:11683
Id:135840df-d00e-5a4b-977c-eea78b76631f
Description:nan